Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Dacomitinib
Dacomitinib
1110813-31-4
|
469.168
|
5.899
Dacomitinib is a medication used to treat non small cell lung cancer with EGFR exon 19 deletion of exon 21 L858R substitution. Dacomitinib is an irreversible small molecule inhibitor of the activity of the human epidermal growth factor receptor family (EGFR/HER1, HER2, and HER4) tyrosine kinases.
Dacomitinib | PF-00299804 | PF299 | PF299804
Dacomitinib is a medication used to treat non small cell lung cancer with EGFR exon 19 deletion of exon 21 L858R substitution. Dacomitinib is an irreversible small molecule inhibitor of the activity of the human epidermal growth factor receptor family (EGFR/HER1, HER2, and HER4) tyrosine kinases.
Dacomitinib | PF-00299804 | PF299 | PF299804
$41/5 mg
(EBC)
1
CAS:1042385-75-0
0
We provide 0 compound for Dacomitinib